Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Management of latent tuberculosis infection (LTBI) among an inner-city population with psychosocial barriers to treatment

FY 2018-19

Summary
Tuberculosis (TB) remains a major global public health threat. TB is the biological expression of social inequality and poverty. Wealthy nations, such as Canada experience relatively low rates overall, but certain sub-populations experience disproportionate burdens of disease. In Canada, the vast majority of cases occur in two minority groups, Indigenous peoples and the foreign-born. A major contributor to active TB disease is the large reservoir of latent TB infection (LTBI), from which active TB develops with its potential to replenish the reservoir. Since LTBI is a necessary precursor to active TB disease, removal of this reservoir is critical to achieving TB elimination goals in Canada. This is achieved through screening and administration of preventative therapy. Long treatment duration and frequent dosing (9 months of twice weekly or daily isoniazid) characterizes the current first choice treatment regimen in Canada. Poor adherence and completion rates among high-risk groups result. In response, an approved shortened treatment regimen with much less frequent dosing has recently been made available in Alberta and Canada. This new regimen is now available to hard-to-reach persons at greatest risk of progressing from LTBI to active TB disease; in particular to individuals with psychosocial barriers to otherwise long treatments. My study will employ a mixed methods design to explore knowledge, attitudes, and perceptions of LTBI and treatment experience. Understanding the patient perspective is critical to reforming preventive TB therapy administration, and promoting adherence. Findings from this study will be applicable to other settings of high TB burden in Canada, and support advocacy efforts related to shorter treatment regimens for underserved populations.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
411253
Name
Lynn Amber T
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Management of latent tuberculosis infection (LTBI) among an inner-city population with psychosocial barriers to treatment
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Descriptive Qualitative; Homelessness; Inner-City; Latent Tuberculosis Infection; Latent Tuberculosis Treatment; Mixed Methods; Patient Oriented Research; Substance Use Disorder; Treatment Adherence
Abstract
Tuberculosis (TB) remains a major global public health threat. TB is the biological expression of social inequality and poverty. Wealthy nations, such as Canada experience relatively low rates overall, but certain sub-populations experience disproportionate burdens of disease. In Canada, the vast majority of cases occur in two minority groups, Indigenous peoples and the foreign-born. A major contributor to active TB disease is the large reservoir of latent TB infection (LTBI), from which active TB develops with its potential to replenish the reservoir. Since LTBI is a necessary precursor to active TB disease, removal of this reservoir is critical to achieving TB elimination goals in Canada. This is achieved through screening and administration of preventative therapy. Long treatment duration and frequent dosing (9 months of twice weekly or daily isoniazid) characterizes the current first choice treatment regimen in Canada. Poor adherence and completion rates among high-risk groups result. In response, an approved shortened treatment regimen with much less frequent dosing has recently been made available in Alberta and Canada. This new regimen is now available to hard-to-reach persons at greatest risk of progressing from LTBI to active TB disease; in particular to individuals with psychosocial barriers to otherwise long treatments. My study will employ a mixed methods design to explore knowledge, attitudes, and perceptions of LTBI and treatment experience. Understanding the patient perspective is critical to reforming preventive TB therapy administration, and promoting adherence. Findings from this study will be applicable to other settings of high TB burden in Canada, and support advocacy efforts related to shorter treatment regimens for underserved populations.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lynn, Amber T
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~